These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26290184)

  • 21. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
    Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
    Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in comparison to severity of morphological changes of the liver].
    Lazareva AS; Volchkova EV; Umbetova KT; Chulanov VP; Parkhomenko IuG; Kiselevskiĭ MV; Pak SG
    Ter Arkh; 2009; 81(4):55-60. PubMed ID: 19514423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
    Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
    BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFI16 is involved in HBV-associated acute-on-chronic liver failure inflammation.
    Pang X; Li X; Mo Z; Huang J; Deng H; Lei Z; Zheng X; Feng Z; Xie D; Gao Z
    BMC Gastroenterol; 2018 May; 18(1):61. PubMed ID: 29743020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.
    Tai DI; Tsai SL; Chen TC; Lo SK; Chang YH; Liaw YF
    J Biomed Sci; 2001; 8(4):321-7. PubMed ID: 11455194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
    Zhang JY; Zhang Z; Lin F; Zou ZS; Xu RN; Jin L; Fu JL; Shi F; Shi M; Wang HF; Wang FS
    Hepatology; 2010 Jan; 51(1):81-91. PubMed ID: 19842207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-E polymorphism and soluble HLA-E plasma levels in chronic hepatitis B patients.
    Zidi I; Laaribi AB; Bortolotti D; Belhadj M; Mehri A; Yahia HB; Babay W; Chaouch H; Zidi N; Letaief A; Yacoub S; Boukadida J; Di Luca D; Hannachi N; Rizzo R
    HLA; 2016 Mar; 87(3):153-9. PubMed ID: 26956431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes.
    Chen C; Liu YH; Cheng SB; Wu SL; Zhai XJ
    Pathol Res Pract; 2020 Apr; 216(4):152875. PubMed ID: 32113793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
    Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients.
    Long Y; Chen E; Liu C; Huang F; Zhou T; He F; Liu L; Liu F; Tang H
    J Viral Hepat; 2009 Aug; 16(8):537-46. PubMed ID: 19302415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between the genotype of hepatitis B virus and clinical and liver pathological features of infected patients in the Zhoushan Islands, China].
    Li SB; Lin ZY; Ding XJ; Li YW; Li SZ; Li CS; Gu RW; Guo WL; Zhi RZ; DU WJ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):179-83. PubMed ID: 17407706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expressive features of HBsAg and HBcAg in the livers of chronic hepatitis B and its clinical significance].
    Le XH; Chen XC; Lin Q; Li MZ; Wang M; Liu SY; Yu ZY; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):41-3. PubMed ID: 17429532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
    Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses].
    Siutkin VE; Lopatkina TN; Popova IV
    Arkh Patol; 1998; 60(6):37-41. PubMed ID: 9949904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B.
    Xu Z; Pan X; Wei K; Ding H; Wei M; Yang H; Liu Q
    Mol Med Rep; 2015 Apr; 11(4):2644-52. PubMed ID: 25524053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.